| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |